Neonatal Hyperthyroidism Due to TSHR p.Thr632Ile Variant With a Suggestive Familial Pattern
- 1Division of Pediatric Endocrinology and Diabetes, University of Alabama at Birmingham, Birmingham, Alabama
- 2Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama
Abstract
Background/Objective: Congenital nonimmune hyperthyroidism due to activating mutations in the thyroid-stimulating hormone receptor (TSHR) is rare and often presents diagnostic and management challenges. We report a case of the TSHR p.Thr632Ile variant, with a maternal clinical history highly suggestive of the same underlying disorder, highlighting diagnostic challenges and clinical variability associated with this mutation.
Case Report: A 2-month-old female presented with severe thyrotoxicosis, feeding intolerance, tachycardia, and failure to thrive. Thyroid receptor antibodies were negative, and genetic testing confirmed a heterozygous pathogenic TSHR p.Thr632Ile variant. Her mother had a history of profound infantile hyperthyroidism, early thyroidectomy with regrowth, and recurrence during adolescence requiring radioactive iodine, features consistent with an activating TSHR mutation. Both the mother and infant demonstrated neurodevelopmental delays.
Discussion: This report provides detailed phenotyping of a TSHR p.Thr632Ile variant, demonstrating persistent severe disease activity, partial resistance to medical therapy, requirement for definitive intervention, and neurodevelopmental impact.
Conclusion: Activating TSHR mutations should be considered in infants with persistent hyperthyroidism. Early genetic diagnosis guides management decisions and genetic counseling.
Related
- Progressive Interstitial Lung Disease Following Hematopoietic Stem Cell Transplantation for Combined Immunodeficiency: A Novel Homozygous SLC7A7 Variant Suggestive of Lysinuric Protein Intolerance
- Familial Multiple Trichoepitheliomas Across Three Generations With a Pathogenic CYLD Variant Identified in One Affected Family Member: A Case Report
- Case Report: Familial TBX4-related developmental lung disease: two siblings with fatal neonatal respiratory failure
- ANOS1 variant and PROK2 upregulation in familial Kallmann syndrome: integrative genetic, transcriptomic, and phenotypic study
- Prevalence and Impact of a Pathogenic CYP27A1 Variant on the Phenotypes Among Patients with Monogenic Heterozygous Familial Hypercholesterolemia
BibTeX
@article{resnick2026neonatal,
title = {{Neonatal Hyperthyroidism Due to TSHR p.Thr632Ile Variant With a Suggestive Familial Pattern}},
author = {Ortal Resnick and Owen Chandler and Giovanna Beauchamp},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
month = jun,
doi = {10.1016/j.aed.2026.06.007},
url = {https://doi.org/10.1016/j.aed.2026.06.007},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Neonatal Hyperthyroidism Due to TSHR p.Thr632Ile Variant With a Suggestive Familial Pattern
AU - Ortal Resnick
AU - Owen Chandler
AU - Giovanna Beauchamp
PY - 2026
DA - 2026/06/17
JO - AACE Endocrinology and Diabetes
DO - 10.1016/j.aed.2026.06.007
UR - https://doi.org/10.1016/j.aed.2026.06.007
AB - Background/Objective: Congenital nonimmune hyperthyroidism due to activating mutations in the thyroid-stimulating hormone receptor (TSHR) is rare and often presents diagnostic and management challenges. We report a case of the TSHR p.Thr632Ile variant, with a maternal clinical history highly suggestive of the same underlying disorder, highlighting diagnostic challenges and clinical variability associated with this mutation. Case Report: A 2-month-old female presented with severe thyrotoxicosis, feeding intolerance, tachycardia, and failure to thrive. Thyroid receptor antibodies were negative, and genetic testing confirmed a heterozygous pathogenic TSHR p.Thr632Ile variant. Her mother had a history of profound infantile hyperthyroidism, early thyroidectomy with regrowth, and recurrence during adolescence requiring radioactive iodine, features consistent with an activating TSHR mutation. Both the mother and infant demonstrated neurodevelopmental delays. Discussion: This report provides detailed phenotyping of a TSHR p.Thr632Ile variant, demonstrating persistent severe disease activity, partial resistance to medical therapy, requirement for definitive intervention, and neurodevelopmental impact. Conclusion: Activating TSHR mutations should be considered in infants with persistent hyperthyroidism. Early genetic diagnosis guides management decisions and genetic counseling.
SN - 3050-9157
ER -